IFITM1 (interferon induced transmembrane protein 1)

2007-02-01  

Identity

HGNC
LOCATION
11p15.5
LOCUSID
ALIAS
9-27,CD225,DSPA2a,IFI17,LEU13
FUSION GENES

Other Information

Locus ID:

NCBI: 8519
MIM: 604456
HGNC: 5412
Ensembl: ENSG00000185885

Variants:

dbSNP: 8519
ClinVar: 8519
TCGA: ENSG00000185885
COSMIC: IFITM1

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000185885ENST00000328221P13164
ENSG00000185885ENST00000408968P13164
ENSG00000185885ENST00000528780P13164

Expression (GTEx)

0
100
200
300
400
500
600
700
800

Pathways

PathwaySourceExternal ID
B cell receptor signaling pathwayKEGGko04662
B cell receptor signaling pathwayKEGGhsa04662
Immune SystemREACTOMER-HSA-168256
Adaptive Immune SystemREACTOMER-HSA-1280218
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cellREACTOMER-HSA-198933
Cytokine Signaling in Immune systemREACTOMER-HSA-1280215
Interferon SignalingREACTOMER-HSA-913531
Interferon alpha/beta signalingREACTOMER-HSA-909733

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
375064912023Genome-wide DNA methylation analysis implicates enrichment of interferon pathway in African American patients with Systemic Lupus Erythematosus and European Americans with lupus nephritis.0
381406312023IFITM1 and IFITM3 Proteins Inhibit the Infectivity of Progeny HIV-1 without Disrupting Envelope Glycoprotein Clusters.1
375064912023Genome-wide DNA methylation analysis implicates enrichment of interferon pathway in African American patients with Systemic Lupus Erythematosus and European Americans with lupus nephritis.0
381406312023IFITM1 and IFITM3 Proteins Inhibit the Infectivity of Progeny HIV-1 without Disrupting Envelope Glycoprotein Clusters.1
357086222022Differential Leukocyte Expression of IFITM1 and IFITM3 in Patients with Severe Pandemic Influenza A(H1N1) and COVID-19.5
357611082022Co-expression of DDR2 and IFITM1 promotes breast cancer cell proliferation, migration and invasion and inhibits apoptosis.4
360089842022Emergent Role of IFITM1/3 towards Splicing Factor (SRSF1) and Antigen-Presenting Molecule (HLA-B) in Cervical Cancer.1
360270392022MiR-504-3p Has Tumor-Suppressing Activity and Decreases IFITM1 Expression in Non-Small Cell Lung Cancer Cells.1
361128782022Toll-like receptor 3 signaling induces interferon-induced transmembrane protein 1 in BEAS-2B cells.0
357086222022Differential Leukocyte Expression of IFITM1 and IFITM3 in Patients with Severe Pandemic Influenza A(H1N1) and COVID-19.5
357611082022Co-expression of DDR2 and IFITM1 promotes breast cancer cell proliferation, migration and invasion and inhibits apoptosis.4
360089842022Emergent Role of IFITM1/3 towards Splicing Factor (SRSF1) and Antigen-Presenting Molecule (HLA-B) in Cervical Cancer.1
360270392022MiR-504-3p Has Tumor-Suppressing Activity and Decreases IFITM1 Expression in Non-Small Cell Lung Cancer Cells.1
361128782022Toll-like receptor 3 signaling induces interferon-induced transmembrane protein 1 in BEAS-2B cells.0
332709272021Opposing activities of IFITM proteins in SARS-CoV-2 infection.147

Citation

Dessen P

IFITM1 (interferon induced transmembrane protein 1)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/43707/ifitm1-(interferon-induced-transmembrane-protein-1)